Also trades as: AION.CN (CNQ) · $vol 0M
ANTCF OTC
Aion Therapeutic Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +17.6%
1Y: +17.6%
3Y: -96.4%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$367K
+0.0% ▲
Gross Profit
$163K
+1042.8% ▲
Operating Income
-$1M
-41.4% ▼
Net Income
-$6M
-2349.6% ▼
EPS (Diluted)
$-0.02
-1216.7% ▼
EBITDA
-$6M
-621.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $367K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $111K | $128K | $65K | $17K | $204K |
| Gross Profit | -$111K | -$128K | -$65K | -$17K | $163K |
| Gross Margin | — | — | — | — | 44.4% |
| R&D Expenses | $18K | $0 | $953K | $0 | $0 |
| SG&A Expenses | $579K | $2M | $1M | $842K | $1M |
| Operating Expenses | $983K | $2M | $2M | $842K | $163K |
| Operating Income | -$997K | -$2M | -$2M | -$842K | -$1M |
| Operating Margin | — | — | — | — | -324.1% |
| Interest Expense | $321K | $186K | $76K | $150K | $171K |
| Income Before Tax | -$673K | -$8M | -$4M | -$257K | -$6M |
| Tax Expense | $321K | $0 | $0 | $0 | $0 |
| Net Income | -$673K | -$8M | -$4M | -$257K | -$6M |
| Net Margin | — | — | — | — | -1710.9% |
| EPS (Diluted) | $-0.02 | $-0.09 | $-0.03 | $-0.00 | $-0.02 |
| EBITDA | -$852K | -$2M | -$2M | -$842K | -$6M |
| Shares Outstanding | 36M | 94M | 140M | 146M | 265M |